AstraZeneca has been approached a couple of times by Chinese authorities about their investigation into the drugmaker's ...
7d
Investor's Business Daily on MSNAstraZeneca Could Pay $4.5 Million In China Scandal. Here's Why Shares Jumped.AstraZeneca stock rose early Thursday after the drugmaker beat fourth-quarter earnings views and delivered upbeat guidance.
A class action lawsuit was filed against AstraZeneca Plc (AZN) by Levi & Korsinsky on December 23, 2024. The plaintiffs ...
A pharma industry group asked the FDA to "take action" against a "dangerous" ad Hims & Hers plans to run during the Super ...
7d
Pharmaceutical Technology on MSNAstraZeneca’s shares rise as it addresses China investigationIn addition to the UK investment controversy, AstraZeneca is also dealing with legal challenges in China. The company ...
The situation escalated with the arrest of Leon Wang, AstraZeneca’s Executive Vice President International and China President. This development, coupled with internal forecasts predicting a ...
AstraZeneca appointed a new president for its China operations following the arrest of former executive Leon Wang along with ...
AstraZeneca on Thursday warned that it could be fined millions of dollars in importation tax fines as Chinese authorities ...
AstraZeneca is expecting Phase III trial data for seven new medicines in 2025, its CEO said as he confirmed the company’s ...
AstraZeneca (AZN.L), opens new tab has been approached a couple of times by Chinese authorities about their investigation into the drugmaker's former senior executive Leon Wang and has provided ...
AstraZeneca said the taxes related to two cancer drugs, Imfinzi and Imjudo, and that it was continuing to co-operate with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results